SCHEMBL22364

SCHEMBL22364

Nc1c(Br)c(C2CCC(=O)CC2)nc2c(-c3ccc(-c4ccccc4)nc3)cnn12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 13/20 0.50
CCNA2 P20248 11/20 0.50
CDK2 P24941 11/20 0.50
CCNA1 P78396 11/20 0.50
MTOR P42345 3/20 0.43
RPTOR Q8N122 3/20 0.43
MLST8 Q9BVC4 3/20 0.43
RPS6KA4 O75676 1/20 0.43
STK10 O94804 1/20 0.43
LATS1 O95835 1/20 0.43
PAK4 O96013 1/20 0.43
RET P07949 1/20 0.43
PIM1 P11309 1/20 0.43
NQO2 P16083 1/20 0.43
CSNK2A2 P19784 1/20 0.43
MARK3 P27448 1/20 0.43
MAP2K2 P36507 1/20 0.43
TGFBR2 P37173 1/20 0.43
PRKCI P41743 1/20 0.43
PSMC4 P43686 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7878863 0.89 CHEK1 (0.57) CHEK1CCNA2CDK2CCNA1MTOR
SCHEMBL7878999 0.89 CHEK1 (0.52) CHEK1CCNA2CDK2CCNA1MTOR
SCHEMBL595514 0.89 CHEK1 (0.52) CHEK1CCNA2CDK2CCNA1MTOR
SCHEMBL596322 0.89 CHEK1 (0.52) CHEK1CCNA2CDK2CCNA1MTOR
SCHEMBL6891867 0.88 CHEK1 (0.49) CHEK1CCNA2CDK2CCNA1MTOR
Bicarbonate SCHEMBL17836471 0.88 CHEK1 (0.49) CHEK1CCNA2CDK2CCNA1MTOR
SCHEMBL6893495 0.88 CHEK1 (0.49) CHEK1CCNA2CDK2CCNA1MTOR
SCHEMBL10235075 0.88 CHEK1 (0.63) CHEK1CCNA2CDK2CCNA1MTOR
Bicarbonate SCHEMBL17836379 0.87 CHEK1 (0.49) CHEK1CCNA2CDK2CCNA1MTOR
Bicarbonate SCHEMBL17836451 0.87 CHEK1 (0.49) CHEK1CCNA2CDK2CCNA1MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed